Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Guidant Corporation
Information provided by:
Gold, Herman K., MD
ClinicalTrials.gov Identifier:
NCT00116792
First received: June 30, 2005
Last updated: May 15, 2007
Last verified: May 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given